Jinhai International Group Holdings Limited ( (HK:2225) ) has shared an update.
Jinhai Medical Technology Limited has issued a profit warning, indicating an expected loss of approximately S$18.1 million for the fiscal year 2024, compared to a loss of S$4.1 million in 2023. Despite a steady development in business operations with increased revenue, the rise in administrative expenses, particularly due to equity-settled share-based payments, has significantly impacted the financial results. Stakeholders are advised to exercise caution and await the audited annual results in March 2025.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the development and provision of medical products and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -26.84%
Average Trading Volume: 4,566,544
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$6.98B
See more insights into 2225 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com